Quince Therapeutics (QNCX) Shares Outstanding (2018 - 2026)

Quince Therapeutics has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $6.1 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2187.34% year-over-year to $6.1 million in Q2 2026; TTM through Jun 2026 was $6.1 million, a 2187.34% increase from a year earlier, with the FY2025 full-year figure at $278626.0, up 26.64% from the prior year.
• Shares Outstanding (Entity) was $6.1 million for Q2 2026 at Quince Therapeutics, up from $456013.0 in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $6.1 million in Q2 2026, with the low at $150748.0 in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $552720.1, with a median of $216229.5 recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) climbed 0.59% in 2023, then soared 2187.34% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $180682.0 in 2022, then rose by 18.92% to $214866.0 in 2023, then grew by 2.39% to $220008.0 in 2024, then rose by 26.64% to $278626.0 in 2025, then soared by 2101.1% to $6.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $6.1 million (Q2 2026), $456013.0 (Q1 2026), and $278626.0 (Q4 2025), per Business Quant data.